Take a trial of UK to unlock this pageFind out more

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value

Margin of Safety (beta)
Screens Passed 1
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2009 2010 2011 2012 2013 2014 2015E 2016E CAGR / Avg
Revenue $m
Operating Profit $m
Net Profit $m
EPS Reported $
EPS Normalised $
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps $
Capex ps $
Free Cashflow ps $
Last ex-div: 16th Apr, paid: 6th May more... Dividends
Dividend ps $
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc $m
Working Capital $m
Net Fixed Assets $m
Net Debt $m
Book Value $m
Average Shares m
Book Value ps $ +13.0%

FINANCIAL BRIEF: For the fiscal year ended 31 December 2014, Smith & Nephew plc revenues increased 6% to $4.62B. Net income decreased 10% to $501M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Acquisition related costs increase from $26M to $95M (expense), Amortisation of acquisition intangibles increase of 47% to $129M (expense). more »

Health Trend

Bankruptcy Risk

  Earnings Manipulation Risk

Magic Formula Score
B-
B-

Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %

vs.
market
vs.
industry
Recent History
Latest interim period (ended 31st Dec '14) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2015
31st Dec 2016

Price Target: $17.9 (+2.81% above Price) Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: +10.4% ($) ($) ($) ($) ($) ($)
Consensus Estimate
1m Change
3m Change
17 brokers Broker Consensus Trend
Broker Recommendations for Smith & Nephew
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 1 11 3 5

Named Brokers and Analysts
Jefferies Martin Brunninger , Credit Suisse Christoph Gretler , Sanford Bernstein Lisa Bedell Clive , Investec Bank (UK) Plc Nicholas Keher , Canaccord Genuity William Plovanic , Brean Capital, LLC Jason Wittes , Nomura Securities , Panmure Gordon Savvas Neophytou , Numis Securities Sally Taylor , Edison Investment Research , Societe Generale Justin Smith , Berenberg Tom Jones , Charles Stanley Rae Ellingham , Shore Capital Stockbrokers Brian White , Morningstar, Inc. Debbie Wang , Day by Day Valérie GASTALDY , Matrix Corporate Capital LLP , and 1 unnamed other

Profile Summary

Smith & Nephew plc is a global medical devices business operating in the markets for advanced surgical devices consisting orthopaedic reconstruction, trauma and sports medicine and advanced wound management. The Company operates in two segments: Advanced Surgical Devices and Advanced Wound Management. The Company’s Advanced Surgical Devices (ASD) segment offers products and technologies include orthopaedic reconstruction, trauma and extremities, sports medicine joint repair, arthroscopy enabling technologies and other ASD. The Company’s Advanced Wound Management (AWM) segment offers products include Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives. The Company operates across the world and has distribution channels in over 90 countries.

Directors: Olivier Bohuon (CEO) 55, Julie Brown (CFO) 51, Rodrigo Bianchi (CEX) 54, Michael Frazzette (CEX) 52, R. Gordon Howe (CEX) 51, Roger Teasdale (CEX) 46, Francisco Vega (CEX) 52, John Campo (OTH) 59, Helen Maye (OTH) 54, Cyrille Petit (OTH) 43, Roberto Quarta (NEC) 64, Vinita Bali (NED) 58, Erik Engstrom (NED) 51, Ian Barlow (NID) 62, Virginia Bottomley (NID) 66,

No. of Employees: 14,000 No. of Shareholders: 0


Last Annual December 31st, 2014
Last Interim December 31st, 2014
Shares in Issue 895,626,076
Free Float 893.4m (99.8%)

SN. Share Price Performance SN. Quote
1150p
9.0  0.8%
Traded 11:31am · Minimum 15 min delayed · NMS: 2.00k

Latest SN. News Announcements (delayed)

Upcoming SN. Events
Wednesday 25th March, 2015
Smith & Nephew PLC Analyst & Investor Meetings
Thursday 9th April, 2015
Smith & Nephew PLC Annual Shareholders Meeting
Thursday 30th April, 2015
Q1 2015 Smith & Nephew PLC Earnings Release
Thursday 30th July, 2015
Q2 2015 Smith & Nephew PLC Earnings Release
Thursday 29th October, 2015
Q3 2015 Smith & Nephew PLC Earnings Release
Friday 8th April, 2016 (estimate)
Smith & Nephew PLC Annual Shareholders Meeting

Recent ↓
Thursday 5th February, 2015
Q4 2014 Smith & Nephew PLC Earnings Call
Thursday 5th February, 2015
Q4 2014 Smith & Nephew Earnings Release
Monday 12th January, 2015
Smith & Nephew PLC at JPMorgan Healthcare Conference
Monday 12th January, 2015
Smith & Nephew PLC at JPMorgan Healthcare Conference
Thursday 4th December, 2014
Smith & Nephew PLC at Berenberg European Conference
Tuesday 11th November, 2014
Smith & Nephew PLC Capital Markets Event
Thursday 30th October, 2014
Q3 2014 Smith & Nephew PLC Earnings Call
Thursday 30th October, 2014
Q3 2014 Smith & Nephew Earnings Release
Wednesday 22nd October, 2014
Dividend For SNN
Tuesday 14th October, 2014
Smith & Nephew PLC Split For SNN


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2015.


Should you buy SN.

Access SN. Analytics Now!

FREE TRIAL or TAKE THE TOUR